Favipiravir (T-705) protects against Nipah virus infection in the hamster model
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Favipiravir (T-705) protects against Nipah virus infection in the hamster model
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-09
DOI
10.1038/s41598-018-25780-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influenza antivirals currently in late-phase clinical trial
- (2017) Paulina Koszalka et al. Influenza and Other Respiratory Viruses
- Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
- (2017) Dustin Siegel et al. JOURNAL OF MEDICINAL CHEMISTRY
- GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo- and Paramyxoviruses
- (2017) Michael K. Lo et al. Scientific Reports
- Antiviral Activity of Favipiravir (T-705) against a Broad Range of ParamyxovirusesIn Vitroand against Human Metapneumovirus in Hamsters
- (2016) D. Jochmans et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimized P2A for reporter gene insertion into Nipah virus results in efficient ribosomal skipping and wild-type lethality
- (2016) Arnold Park et al. JOURNAL OF GENERAL VIROLOGY
- Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir
- (2016) Brian B. Gowen et al. JOURNAL OF VIROLOGY
- Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
- (2016) Daouda Sissoko et al. PLOS MEDICINE
- Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
- (2016) Hideki Tani et al. mSphere
- Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever
- (2015) Brian B. Gowen et al. ANTIVIRAL RESEARCH
- Henipavirus Encephalitis: Recent Developments and Advances
- (2015) Kien Chai Ong et al. BRAIN PATHOLOGY
- Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
- (2015) Kentaro Yamada et al. JOURNAL OF INFECTIOUS DISEASES
- The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
- (2015) David Safronetz et al. Scientific Reports
- Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- (2014) Lisa Oestereich et al. ANTIVIRAL RESEARCH
- Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment
- (2014) Dionna Scharton et al. ANTIVIRAL RESEARCH
- Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral
- (2014) Leen Delang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Recombinant Hendra Virus G Glycoprotein Subunit Vaccine Protects Nonhuman Primates against Hendra Virus Challenge
- (2014) C. E. Mire et al. JOURNAL OF VIROLOGY
- Efficient Reverse Genetics Reveals Genetic Determinants of Budding and Fusogenic Differences between Nipah and Hendra Viruses and Enables Real-Time Monitoring of Viral Spread in Small Animal Models of Henipavirus Infection
- (2014) Tatyana Yun et al. JOURNAL OF VIROLOGY
- Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody
- (2014) T. W. Geisbert et al. Science Translational Medicine
- Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins
- (2014) Blair L. DeBuysscher et al. VACCINE
- Evidence for henipavirus spillover into human populations in Africa
- (2014) Olivier Pernet et al. Nature Communications
- Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
- (2014) Lisa Oestereich et al. PLoS Neglected Tropical Diseases
- Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
- (2013) Hidehiro Sangawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The pandemic potential of Nipah virus
- (2013) Stephen P. Luby ANTIVIRAL RESEARCH
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters
- (2013) Michael K. Lo et al. ANTIVIRAL RESEARCH
- Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
- (2013) Brian B. Gowen et al. PLoS Neglected Tropical Diseases
- Recent progress in henipavirus research: Molecular biology, genetic diversity, animal models
- (2012) Barry Rockx et al. ANTIVIRAL RESEARCH
- A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity
- (2012) Antonello Pessi et al. PLoS One
- Clinical Outcome of Henipavirus Infection in Hamsters Is Determined by the Route and Dose of Infection
- (2011) B. Rockx et al. JOURNAL OF VIROLOGY
- A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge
- (2011) K. N. Bossart et al. Science Translational Medicine
- A Novel Model of Lethal Hendra Virus Infection in African Green Monkeys and the Effectiveness of Ribavirin Treatment
- (2010) B. Rockx et al. JOURNAL OF VIROLOGY
- Inhibition of Nipah Virus Infection In Vivo: Targeting an Early Stage of Paramyxovirus Fusion Activation during Viral Entry
- (2010) Matteo Porotto et al. PLoS Pathogens
- Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection
- (2009) A. N. Freiberg et al. JOURNAL OF GENERAL VIROLOGY
- Chloroquine Administration Does Not Prevent Nipah Virus Infection and Disease in Ferrets
- (2009) J. Pallister et al. JOURNAL OF VIROLOGY
- Henipavirus RNA in African Bats
- (2009) Jan Felix Drexler et al. PLoS One
- T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
- (2009) M. Kiso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection
- (2009) Katharine N. Bossart et al. PLoS Pathogens
- Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin
- (2008) Brian B. Gowen et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More